Creating a database for understanding peritoneal carcinosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a prospective clinical and biological database focused on peritoneal carcinosis, a type of cancer that affects the peritoneum. By collecting blood and tissue samples from patients, researchers hope to gain insights into the mechanisms of carcinosis and develop targeted treatments. The study involves patients over 18 years old who are undergoing treatment for peritoneal carcinosis, ensuring that the data collected will be relevant and useful for future research. Informed consent is required from all participants to proceed with sample collection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient over the age of 18;
* Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
* Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
* Patient agree will all study procedure : biological samples \& tissues samples
* Patient giving informed consent

Exclusion Criteria:

* Patient not affiliated to Social Protection system
* Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
* The level of French is insufficient to consent to the study and to response to the questionnaires
* Patient under guardianship
* Pregnancy ou breast-feeding women
* Patient treated in case of an emergency

Where it's running

• Institut du cancer de Montpellier ICM
  Montpellier, France Recruiting

Study contacts

• Study coordinator: Aurore MOUSSION
• Email: aurore.moussion@icm.unicancer.fr
• Phone: 467613100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Single‑session high‑dose lung radiotherapy and its effects on outcomes and quality of life

  This study tests whether a single high‑dose session of SBRT (30–34 Gy) works and how it affects quality of life for adults with small primary non‑small cell lung cancers or up to three lung metastases who are inoperable or refuse surgery.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, ICM and 1 other locations · NCT07441941

• Prehabilitation with physiotherapy and mechanical stimulation before LD flap breast reconstruction

  This study tests whether prehabilitation with physiotherapy and mechanostimulation improves shoulder pain and mobility for women undergoing breast reconstruction with a latissimus dorsi flap.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Bordeaux, Aquitaine and 1 other locations · NCT07418060

• Music therapy with a tobacco‑addiction nurse to help people with cancer quit smoking

  This project will try whether personalized music therapy combined with support from a tobacco‑addiction nurse helps people with cancer who smoke reduce withdrawal symptoms and quit.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, Herault · NCT07198971

• Preserving the superior left colic artery to improve blood flow to the descending colon before reconnecting the bowel after left-sided, rectal, or ovarian cancer surgery

  This trial will test in adults having left colon, rectal, or ovarian cancer surgery whether preserving the superior left colic artery and temporarily managing the inferior mesenteric artery improves blood flow to the descending colon and reduces healing problems after the bowel is reconnected.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, Herault · NCT07098182

• Biobank for bronchial cancer patients to support research

  A biobank project will collect blood and tissue samples from adults with bronchial cancer to help researchers study biology and improve future treatments.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, France · NCT07085429

• Analysis of circulating tumor markers in blood in lung cancer patients

  This study tests whether blood-based tumor markers can help understand and monitor lung cancer in adults to complement tissue tests.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, France · NCT07060950

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.